We found an increase in the frequency of PD-1+ and LAG3+ B cells in the plasma of HNSCC patients as compared to healthy individuals (Figure 1), which parallels findings from studies of hepatocellular and thyroid cancer patients [18,21,22]. This evidence concerns the gene LAG3 and thyroid gland carcinoma.